Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2024 12:18 ET | Source: Research and Markets

Emerging ONC201 Drug Set to Transform Glioblastoma Multiforme Treatment Landscape: Drug Insights and Market Forecasts to 2032

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "ONC201 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
January 29, 2024 12:17 ET | Source: Research and Markets

PF-06425090 (C. difficile Vaccine): Pharmaceutical Development and Market Forecast Insights to 2032

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "PF-06425090 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report casts light...
January 24, 2024 10:44 ET | Source: Research and Markets

Paroxysmal Nocturnal Hemoglobinuria Treatment Advances with Comprehensive Danicopan Market Forecast to 2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Danicopan Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The global healthcare...
January 24, 2024 09:23 ET | Source: Research and Markets

Glofitamab (CD20-TCB, RG6026) for Diffuse Large B-cell lLymphoma (DLBCL) - Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Glofitamab Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
January 24, 2024 09:17 ET | Source: Research and Markets

LUNSUMIO (mosunetuzumab, RG7828) for Diffuse Large B-cell lymphoma (DLBCL) in 7 Major Markets - Emerging Drug Insight and Market Forecasts, 2019-2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "LUNSUMIO Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
January 24, 2024 09:14 ET | Source: Research and Markets

Otenaproxesul for Osteoarthritis: A Novel NSAID that Releases Hydrogen Sulfide - Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Otenaproxesul Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
January 24, 2024 09:12 ET | Source: Research and Markets

Emerging Drug Insight and Market Forecasts for YG1699 in Type 1 Diabetes Mellitus, 2019-2023 and 2023-2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "YG1699 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Understanding the future market...
January 24, 2024 09:11 ET | Source: Research and Markets

REMD-477 (Volagidemab) for Type 1 Diabetes Mellitus: Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032 - Focus on 7 Major Markets

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "REMD-477 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
January 24, 2024 09:09 ET | Source: Research and Markets

ITI-1000 (pp65 DC vaccine) for Glioblastoma Multiforme (GBM): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032 - Focus on US, Germany, France, Italy, Spain, UK, and Japan

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ITI-1000 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
January 24, 2024 09:06 ET | Source: Research and Markets

EO 2401 for GBM: A Donor-Derived, Off-the-Shelf, Microbiome Therapeutic Cancer Peptide Vaccine - Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "EO 2401 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...